Julia publicover
Director, Translational Research & Innovation University Health Network
Julia Publicover, MSc, PMP, is Director of Translational Research and Innovation at the University Health Network (UHN) in Toronto, where she leads initiatives across molecular imaging and theranostics. Her portfolio spans core facilities including QIPCM and the UHN Radiotheranostics Core, supporting clinical trials, radiopharmaceutical production, and imaging science. With a background in medical physics and radioisotope development, Julia focuses on translating innovation into clinical impact. She works closely with industry, clinicians, and researchers to build integrated ecosystems that accelerate the development, evaluation, and adoption of targeted radiopharmaceuticals within large academic health systems.
Seminars
- Building strategic partnerships across the radiopharmaceutical lifecycle – from discovery research and preclinical development through clinical trials, manufacturing, commercialization, and patient care.
- Creating integrated infrastructure that accelerates translation – leveraging capabilities such as multi-centre imaging trials, translational research platforms, radiopharmaceutical production, and Phase 0 clinical development to move innovations from concept to clinic more efficiently.
- Translating innovation into clinical and commercial impact through collaborative models – highlighting lessons learned from industry partnerships that support clinical validation, evidence generation, commercialization, and the adoption of novel radiopharmaceutical therapies. The UHN 177Lu-DOTATATE experience illustrates how academic research, clinical trials, dosimetry development, and commercialization can collectively advance new therapies from concept to patient care.
- Building a collaborative radiopharmaceutical ecosystem – fostering ongoing dialogue, education, and advocacy among academia, industry, government, and healthcare providers to support innovation and patient access.
